Arlington Trust’s Neogen NEOG Stock Holding History

Arlington Trust’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-123	Closed	-$2.47K	–	747
2023 Q4	$2.47K	Buy	+123	New	+$2.08K	﹤0.01%	591

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Arlington Trust's NEOG Position: Q1 2024 in Review

Arlington Trust sold out of Neogen (NEOG) in Q1 2024, closing a stake of 123 shares — an estimated $2.47K sold.

Arlington Trust first reported a position in NEOG in Q4 2023 and held it in 1 quarter. The position peaked at $2.47K in Q4 2023. 343 funds tracked by Wall St. Rank hold NEOG as of Q1 2024.

Arlington Trust reported no remaining Neogen position as of Q1 2024 after selling out during the quarter.
Arlington Trust sold 123 Neogen shares in Q1 2024, an estimated $2.47K.
Arlington Trust first reported a position in Neogen in Q4 2023 and held it in 1 quarter.
Arlington Trust's Neogen position peaked at $2.47K in Q4 2023.
343 funds tracked by Wall St. Rank held Neogen as of Q1 2024.

Based on Arlington Trust's 13F filing for Q1 2024, filed 16 Apr 2024.